在肝癌中对cuproptosis和ferroptosis的免疫调节
Jia-Qian Mo1, Shen-Yan Zhang1, Qiang Li1
1School of Life Sciences and Biopharmaceutics, Guang Dong Pharmaceutical University, Guangzhou, 51006, China.
Cancer cell international
|January 10, 2024
概括
新兴研究强调了结合铜 (铜诱导的细胞死亡) 和铁 (依赖铁的细胞死亡) 作为治疗肝癌的新治疗策略的潜力,为晚期病例提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 细胞死亡机制 细胞死亡机制
- 肝细胞癌研究 肝细胞癌研究
背景情况:
- 肝癌发病率正在上升,需要超越手术切除的先进治疗策略.
- 目前的治疗方法对于晚期肝癌患者来说是不够的,这促使人们寻找新的治疗方法.
- 铁亡和亡是最近定义的细胞死亡途径,在癌症治疗中显示出希望.
研究的目的:
- 审查目前关于结合cuproptosis和ferroptosis用于肝癌治疗的研究.
- 分析这些细胞死亡途径在肝癌免疫中的作用.
- 提出潜在的瘤治疗途径,利用杯和铁的组合.
主要方法:
- 文献综述总结了肝癌中cuproptosis和ferroptosis的研究进展.
- 分析肝细胞癌中cuproptosis和ferroptosis的免疫调节作用.
- 探索潜在的治疗机制和途径,用于联合cuproptosis-ferroptosis疗法.
主要成果:
- 铁和都在抑制肝细胞癌细胞增殖方面表现出显著的潜力.
- 和铁的结合是提高肝癌治疗疗效的有希望的策略.
- 了解这些细胞死亡模式与瘤免疫微环境之间的相互作用至关重要.
结论:
- 结合cuproptosis和ferroptosis为肝癌提供了一种新且有前途的治疗途径,特别是对于晚期的肝癌.
- 需要进一步研究结合性铁亡和亡的协同机制和免疫影响.
- 这种治疗组合有可能改善患者的预后,并开发出更有效的肝癌治疗方法.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
365
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
